Key Secret behind DermTech, Inc. (DMTK) surge in the Afterhours
DermTech, Inc. (NASDAQ: DMTK) stock was rising 27.83% to reach $18.28 in the aftermarket following the published the topline results of the TRUST Study, a non-invasive melanoma rule-out test using the Pigmented Lesion Assay. The TRUST study was intended to assess the long-term outcomes of the PLA negative results of pigmented skin lesions. It also […]